Silva, Diosdada M.

HRN: 01-89-88  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/18/2026
04/24/2026
IV
4.5g
Q8
Sepsis; CAP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: